又又又超预期！安捷伦Q3营收同比增长10.1%，核心收入连增5季

Core Insights - Agilent Technologies reported Q3 2025 revenue of $1.74 billion, a year-over-year increase of 10.1%, with core operating income growing by 6.1% [2][4] - The company achieved revenue growth across all three business segments and major global regions, with growth rates exceeding 5% [2][6] - Following the earnings announcement, Agilent's stock price rose by 3%, indicating investor confidence in the company's strong revenue performance [2] Business Segment Performance - The Life Sciences and Diagnostics Group (LDG) generated $667 million in revenue, reflecting a 14.5% year-over-year increase and a 2.4% quarter-over-quarter increase, driven by strong demand in LC/LC-MS and CDMO services for siRNA and GLP-1 [6] - The Agilent CrossLab Group (ACG) reported $744 million in revenue, up 7.7% year-over-year and 4.3% quarter-over-quarter, with sales boosted by inventory stocking in China due to the US-China tariff situation [6] - The Applied Markets Group (AMG) achieved revenue of $324 million, marking a 7.3% year-over-year increase and a 7.6% quarter-over-quarter increase [6] Future Outlook - Agilent raised its full-year revenue guidance to between $6.91 billion and $6.93 billion, representing a growth of 6.2% to 6.5%, marking the third upward revision of the fiscal year [6] - The company anticipates Q4 revenue to be between $1.822 billion and $1.842 billion, significantly above the consensus estimate of $1.75 billion, with adjusted earnings per share expected to be between $1.57 and $1.60 [6]